Loading…
Autoimmune thyroid disease in Colombian patients with systemic lupus erythematosus
Summary Objectives To determine the prevalence and the predictive factors of autoimmune hypothyroidism (AH) within a systemic lupus erythematosus (SLE) cohort and to analyse the current information concerning the prevalence and impact of autoimmune thyroid disease (AITD) and thyroid autoimmunity in...
Saved in:
Published in: | Clinical endocrinology (Oxford) 2015-12, Vol.83 (6), p.943-950 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 950 |
container_issue | 6 |
container_start_page | 943 |
container_title | Clinical endocrinology (Oxford) |
container_volume | 83 |
creator | Franco, Juan-Sebastian Amaya-Amaya, Jenny Molano-González, Nicolás Caro-Moreno, Julian Rodríguez-Jiménez, Mónica Acosta-Ampudia, Yeny Mantilla, Rubén D. Rojas-Villarraga, Adriana Anaya, Juan-Manuel |
description | Summary
Objectives
To determine the prevalence and the predictive factors of autoimmune hypothyroidism (AH) within a systemic lupus erythematosus (SLE) cohort and to analyse the current information concerning the prevalence and impact of autoimmune thyroid disease (AITD) and thyroid autoimmunity in patients with SLE.
Methods
A total of 376 patients with SLE were assessed for the presence of the following: (i) confirmed AH, (ii) positive thy‐roperoxidase/thyroglobulin antibodies [TPOAb/TgAb] without hypothyroidism, (iii) nonautoimmune hypothyroidism and (iv) SLE patients with neither. Multivariate analysis and a classification and regression tree model were used to analyse data. The current information was discussed through a systematic literature review (SLR).
Results
In our cohort, the prevalence of confirmed AH was 12%. However, in euthyroid patients with SLE, TPOAb and TgAb were observed in 21% and 10%, respectively. Patients with confirmed AH were significantly older and had later age at onset of the disease. Smoking (adjusted odds ratio (AOR) 6·93, 95% CI 1·98–28·54, P = 0·004), Sjögren's Syndrome (SS) (AOR 23·2, 95% CI 1·89–359·53, P = 0·015) and positivity for anticyclic citrullinated peptide (anti‐CCP) (AOR 10·35, 95% CI 1·04–121·26, P = 0·047) were associated with AH‐SLE, regardless of gender and duration of the disease. Smoking and SS were confirmed as predictors of AH‐SLE. In the SLR, the prevalence of AITD ranged from 1% to 60%. The factors associated with this polyautoimmunity were female gender, older age, smoking, certain autoantibodies, SS, and cutaneous and articular involvement.
Conclusions
AITD is frequent in SLE and does not affect the severity of SLE. Identified risk factors will assist clinicians in the search for AITD. Our results encourage smoke‐free policies in patients with SLE. |
doi_str_mv | 10.1111/cen.12662 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1760886712</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1760886712</sourcerecordid><originalsourceid>FETCH-LOGICAL-i3522-f141edb92d202df330c1a9e2d7554346ae2805b77cbd850b0a007b9e0fbbe7213</originalsourceid><addsrcrecordid>eNpd0ctuGyEUBmBUNWoct4u-QIXUTTcTH8DAeBmNclOsJGoTdYlg5lgmnYs7gNJ5-9A4ySJsQOL7ETo_IV8ZHLO8FjX2x4wrxT-QGRNKFpwr-ZHMQAAUoNTykByF8AAAsgT9iRxyKcps1Iz8PElx8F2XeqRxO42Db2jjA9qA1Pe0Gtqhc972dGejxz4G-ujjloYpROx8Tdu0S4HiOMUtdjYOIYXP5GBj24BfXvY5uT87vasuivXN-WV1si68kJwXG7Zk2LgVbzjwZiME1MyukDdayqVYKou8BOm0rl1TSnBgAbRbIWycQ82ZmJMf-3d34_A3YYim86HGtrU9DikYphWUpdKMZ_r9HX0Y0tjn32Uls-BKq6y-vajkOmzMbvSdHSfzOq0MFnvw6Fuc3u4ZmP81mFyDea7BVKfXz4ecKPYJn-f17y1hxz9GaaGl-X19bqrbK1790qVZiyc7FIjT</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1757122676</pqid></control><display><type>article</type><title>Autoimmune thyroid disease in Colombian patients with systemic lupus erythematosus</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Franco, Juan-Sebastian ; Amaya-Amaya, Jenny ; Molano-González, Nicolás ; Caro-Moreno, Julian ; Rodríguez-Jiménez, Mónica ; Acosta-Ampudia, Yeny ; Mantilla, Rubén D. ; Rojas-Villarraga, Adriana ; Anaya, Juan-Manuel</creator><creatorcontrib>Franco, Juan-Sebastian ; Amaya-Amaya, Jenny ; Molano-González, Nicolás ; Caro-Moreno, Julian ; Rodríguez-Jiménez, Mónica ; Acosta-Ampudia, Yeny ; Mantilla, Rubén D. ; Rojas-Villarraga, Adriana ; Anaya, Juan-Manuel</creatorcontrib><description>Summary
Objectives
To determine the prevalence and the predictive factors of autoimmune hypothyroidism (AH) within a systemic lupus erythematosus (SLE) cohort and to analyse the current information concerning the prevalence and impact of autoimmune thyroid disease (AITD) and thyroid autoimmunity in patients with SLE.
Methods
A total of 376 patients with SLE were assessed for the presence of the following: (i) confirmed AH, (ii) positive thy‐roperoxidase/thyroglobulin antibodies [TPOAb/TgAb] without hypothyroidism, (iii) nonautoimmune hypothyroidism and (iv) SLE patients with neither. Multivariate analysis and a classification and regression tree model were used to analyse data. The current information was discussed through a systematic literature review (SLR).
Results
In our cohort, the prevalence of confirmed AH was 12%. However, in euthyroid patients with SLE, TPOAb and TgAb were observed in 21% and 10%, respectively. Patients with confirmed AH were significantly older and had later age at onset of the disease. Smoking (adjusted odds ratio (AOR) 6·93, 95% CI 1·98–28·54, P = 0·004), Sjögren's Syndrome (SS) (AOR 23·2, 95% CI 1·89–359·53, P = 0·015) and positivity for anticyclic citrullinated peptide (anti‐CCP) (AOR 10·35, 95% CI 1·04–121·26, P = 0·047) were associated with AH‐SLE, regardless of gender and duration of the disease. Smoking and SS were confirmed as predictors of AH‐SLE. In the SLR, the prevalence of AITD ranged from 1% to 60%. The factors associated with this polyautoimmunity were female gender, older age, smoking, certain autoantibodies, SS, and cutaneous and articular involvement.
Conclusions
AITD is frequent in SLE and does not affect the severity of SLE. Identified risk factors will assist clinicians in the search for AITD. Our results encourage smoke‐free policies in patients with SLE.</description><identifier>ISSN: 0300-0664</identifier><identifier>EISSN: 1365-2265</identifier><identifier>DOI: 10.1111/cen.12662</identifier><identifier>PMID: 25382266</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>Adolescent ; Adult ; Autoimmunity - physiology ; Cross-Sectional Studies ; Female ; Hashimoto Disease - etiology ; Hashimoto Disease - pathology ; Humans ; Hypothyroidism - etiology ; Hypothyroidism - pathology ; Lupus Erythematosus, Systemic - complications ; Lupus Erythematosus, Systemic - pathology ; Male ; Middle Aged ; Multivariate Analysis ; Thyroiditis, Autoimmune - etiology ; Thyroiditis, Autoimmune - pathology ; Young Adult</subject><ispartof>Clinical endocrinology (Oxford), 2015-12, Vol.83 (6), p.943-950</ispartof><rights>2014 John Wiley & Sons Ltd</rights><rights>2014 John Wiley & Sons Ltd.</rights><rights>Copyright © 2015 John Wiley & Sons Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25382266$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Franco, Juan-Sebastian</creatorcontrib><creatorcontrib>Amaya-Amaya, Jenny</creatorcontrib><creatorcontrib>Molano-González, Nicolás</creatorcontrib><creatorcontrib>Caro-Moreno, Julian</creatorcontrib><creatorcontrib>Rodríguez-Jiménez, Mónica</creatorcontrib><creatorcontrib>Acosta-Ampudia, Yeny</creatorcontrib><creatorcontrib>Mantilla, Rubén D.</creatorcontrib><creatorcontrib>Rojas-Villarraga, Adriana</creatorcontrib><creatorcontrib>Anaya, Juan-Manuel</creatorcontrib><title>Autoimmune thyroid disease in Colombian patients with systemic lupus erythematosus</title><title>Clinical endocrinology (Oxford)</title><addtitle>Clin Endocrinol</addtitle><description>Summary
Objectives
To determine the prevalence and the predictive factors of autoimmune hypothyroidism (AH) within a systemic lupus erythematosus (SLE) cohort and to analyse the current information concerning the prevalence and impact of autoimmune thyroid disease (AITD) and thyroid autoimmunity in patients with SLE.
Methods
A total of 376 patients with SLE were assessed for the presence of the following: (i) confirmed AH, (ii) positive thy‐roperoxidase/thyroglobulin antibodies [TPOAb/TgAb] without hypothyroidism, (iii) nonautoimmune hypothyroidism and (iv) SLE patients with neither. Multivariate analysis and a classification and regression tree model were used to analyse data. The current information was discussed through a systematic literature review (SLR).
Results
In our cohort, the prevalence of confirmed AH was 12%. However, in euthyroid patients with SLE, TPOAb and TgAb were observed in 21% and 10%, respectively. Patients with confirmed AH were significantly older and had later age at onset of the disease. Smoking (adjusted odds ratio (AOR) 6·93, 95% CI 1·98–28·54, P = 0·004), Sjögren's Syndrome (SS) (AOR 23·2, 95% CI 1·89–359·53, P = 0·015) and positivity for anticyclic citrullinated peptide (anti‐CCP) (AOR 10·35, 95% CI 1·04–121·26, P = 0·047) were associated with AH‐SLE, regardless of gender and duration of the disease. Smoking and SS were confirmed as predictors of AH‐SLE. In the SLR, the prevalence of AITD ranged from 1% to 60%. The factors associated with this polyautoimmunity were female gender, older age, smoking, certain autoantibodies, SS, and cutaneous and articular involvement.
Conclusions
AITD is frequent in SLE and does not affect the severity of SLE. Identified risk factors will assist clinicians in the search for AITD. Our results encourage smoke‐free policies in patients with SLE.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Autoimmunity - physiology</subject><subject>Cross-Sectional Studies</subject><subject>Female</subject><subject>Hashimoto Disease - etiology</subject><subject>Hashimoto Disease - pathology</subject><subject>Humans</subject><subject>Hypothyroidism - etiology</subject><subject>Hypothyroidism - pathology</subject><subject>Lupus Erythematosus, Systemic - complications</subject><subject>Lupus Erythematosus, Systemic - pathology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Multivariate Analysis</subject><subject>Thyroiditis, Autoimmune - etiology</subject><subject>Thyroiditis, Autoimmune - pathology</subject><subject>Young Adult</subject><issn>0300-0664</issn><issn>1365-2265</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNpd0ctuGyEUBmBUNWoct4u-QIXUTTcTH8DAeBmNclOsJGoTdYlg5lgmnYs7gNJ5-9A4ySJsQOL7ETo_IV8ZHLO8FjX2x4wrxT-QGRNKFpwr-ZHMQAAUoNTykByF8AAAsgT9iRxyKcps1Iz8PElx8F2XeqRxO42Db2jjA9qA1Pe0Gtqhc972dGejxz4G-ujjloYpROx8Tdu0S4HiOMUtdjYOIYXP5GBj24BfXvY5uT87vasuivXN-WV1si68kJwXG7Zk2LgVbzjwZiME1MyukDdayqVYKou8BOm0rl1TSnBgAbRbIWycQ82ZmJMf-3d34_A3YYim86HGtrU9DikYphWUpdKMZ_r9HX0Y0tjn32Uls-BKq6y-vajkOmzMbvSdHSfzOq0MFnvw6Fuc3u4ZmP81mFyDea7BVKfXz4ecKPYJn-f17y1hxz9GaaGl-X19bqrbK1790qVZiyc7FIjT</recordid><startdate>201512</startdate><enddate>201512</enddate><creator>Franco, Juan-Sebastian</creator><creator>Amaya-Amaya, Jenny</creator><creator>Molano-González, Nicolás</creator><creator>Caro-Moreno, Julian</creator><creator>Rodríguez-Jiménez, Mónica</creator><creator>Acosta-Ampudia, Yeny</creator><creator>Mantilla, Rubén D.</creator><creator>Rojas-Villarraga, Adriana</creator><creator>Anaya, Juan-Manuel</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7QP</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>201512</creationdate><title>Autoimmune thyroid disease in Colombian patients with systemic lupus erythematosus</title><author>Franco, Juan-Sebastian ; Amaya-Amaya, Jenny ; Molano-González, Nicolás ; Caro-Moreno, Julian ; Rodríguez-Jiménez, Mónica ; Acosta-Ampudia, Yeny ; Mantilla, Rubén D. ; Rojas-Villarraga, Adriana ; Anaya, Juan-Manuel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-i3522-f141edb92d202df330c1a9e2d7554346ae2805b77cbd850b0a007b9e0fbbe7213</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Autoimmunity - physiology</topic><topic>Cross-Sectional Studies</topic><topic>Female</topic><topic>Hashimoto Disease - etiology</topic><topic>Hashimoto Disease - pathology</topic><topic>Humans</topic><topic>Hypothyroidism - etiology</topic><topic>Hypothyroidism - pathology</topic><topic>Lupus Erythematosus, Systemic - complications</topic><topic>Lupus Erythematosus, Systemic - pathology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Multivariate Analysis</topic><topic>Thyroiditis, Autoimmune - etiology</topic><topic>Thyroiditis, Autoimmune - pathology</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Franco, Juan-Sebastian</creatorcontrib><creatorcontrib>Amaya-Amaya, Jenny</creatorcontrib><creatorcontrib>Molano-González, Nicolás</creatorcontrib><creatorcontrib>Caro-Moreno, Julian</creatorcontrib><creatorcontrib>Rodríguez-Jiménez, Mónica</creatorcontrib><creatorcontrib>Acosta-Ampudia, Yeny</creatorcontrib><creatorcontrib>Mantilla, Rubén D.</creatorcontrib><creatorcontrib>Rojas-Villarraga, Adriana</creatorcontrib><creatorcontrib>Anaya, Juan-Manuel</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical endocrinology (Oxford)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Franco, Juan-Sebastian</au><au>Amaya-Amaya, Jenny</au><au>Molano-González, Nicolás</au><au>Caro-Moreno, Julian</au><au>Rodríguez-Jiménez, Mónica</au><au>Acosta-Ampudia, Yeny</au><au>Mantilla, Rubén D.</au><au>Rojas-Villarraga, Adriana</au><au>Anaya, Juan-Manuel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Autoimmune thyroid disease in Colombian patients with systemic lupus erythematosus</atitle><jtitle>Clinical endocrinology (Oxford)</jtitle><addtitle>Clin Endocrinol</addtitle><date>2015-12</date><risdate>2015</risdate><volume>83</volume><issue>6</issue><spage>943</spage><epage>950</epage><pages>943-950</pages><issn>0300-0664</issn><eissn>1365-2265</eissn><abstract>Summary
Objectives
To determine the prevalence and the predictive factors of autoimmune hypothyroidism (AH) within a systemic lupus erythematosus (SLE) cohort and to analyse the current information concerning the prevalence and impact of autoimmune thyroid disease (AITD) and thyroid autoimmunity in patients with SLE.
Methods
A total of 376 patients with SLE were assessed for the presence of the following: (i) confirmed AH, (ii) positive thy‐roperoxidase/thyroglobulin antibodies [TPOAb/TgAb] without hypothyroidism, (iii) nonautoimmune hypothyroidism and (iv) SLE patients with neither. Multivariate analysis and a classification and regression tree model were used to analyse data. The current information was discussed through a systematic literature review (SLR).
Results
In our cohort, the prevalence of confirmed AH was 12%. However, in euthyroid patients with SLE, TPOAb and TgAb were observed in 21% and 10%, respectively. Patients with confirmed AH were significantly older and had later age at onset of the disease. Smoking (adjusted odds ratio (AOR) 6·93, 95% CI 1·98–28·54, P = 0·004), Sjögren's Syndrome (SS) (AOR 23·2, 95% CI 1·89–359·53, P = 0·015) and positivity for anticyclic citrullinated peptide (anti‐CCP) (AOR 10·35, 95% CI 1·04–121·26, P = 0·047) were associated with AH‐SLE, regardless of gender and duration of the disease. Smoking and SS were confirmed as predictors of AH‐SLE. In the SLR, the prevalence of AITD ranged from 1% to 60%. The factors associated with this polyautoimmunity were female gender, older age, smoking, certain autoantibodies, SS, and cutaneous and articular involvement.
Conclusions
AITD is frequent in SLE and does not affect the severity of SLE. Identified risk factors will assist clinicians in the search for AITD. Our results encourage smoke‐free policies in patients with SLE.</abstract><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>25382266</pmid><doi>10.1111/cen.12662</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0300-0664 |
ispartof | Clinical endocrinology (Oxford), 2015-12, Vol.83 (6), p.943-950 |
issn | 0300-0664 1365-2265 |
language | eng |
recordid | cdi_proquest_miscellaneous_1760886712 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | Adolescent Adult Autoimmunity - physiology Cross-Sectional Studies Female Hashimoto Disease - etiology Hashimoto Disease - pathology Humans Hypothyroidism - etiology Hypothyroidism - pathology Lupus Erythematosus, Systemic - complications Lupus Erythematosus, Systemic - pathology Male Middle Aged Multivariate Analysis Thyroiditis, Autoimmune - etiology Thyroiditis, Autoimmune - pathology Young Adult |
title | Autoimmune thyroid disease in Colombian patients with systemic lupus erythematosus |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T20%3A53%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Autoimmune%20thyroid%20disease%20in%20Colombian%20patients%20with%20systemic%20lupus%20erythematosus&rft.jtitle=Clinical%20endocrinology%20(Oxford)&rft.au=Franco,%20Juan-Sebastian&rft.date=2015-12&rft.volume=83&rft.issue=6&rft.spage=943&rft.epage=950&rft.pages=943-950&rft.issn=0300-0664&rft.eissn=1365-2265&rft_id=info:doi/10.1111/cen.12662&rft_dat=%3Cproquest_pubme%3E1760886712%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-i3522-f141edb92d202df330c1a9e2d7554346ae2805b77cbd850b0a007b9e0fbbe7213%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1757122676&rft_id=info:pmid/25382266&rfr_iscdi=true |